Bio-Rad Laboratories QX ONE Droplet Digital PCR System Endpoint Fluorescence Quantification
Near-new, with very little prior use and minimal cosmetic wear. Found in working order at our intake inspection. Sold as received, without reconditioning.
Bio-Rad Laboratories
Details
-
CategoryMolecular Biology
-
Dimension26.0in x 48.0in x 30.0in
-
Serial766BR2223
-
Shipping TypeFedEx Ground
-
Manufacturing2023-08-01
-
Voltage / Hertz100-240 vac
Description
Bio-Rad Laboratories QX ONE droplet digital PCR system, manufactured 2023-08. This near-new QX ONE instrument was found in working order during intake inspection with minimal cosmetic wear. Designed for droplet partitioning of PCR reactions into thousands of nanoliter droplets, it supports endpoint fluorescence-based quantification for molecular biology and genomics workflows. The unit is listed as received from our intake process, with condition reflecting very light prior use and clean overall appearance. Ideal for ddPCR applications where precise absolute quantification and sensitive detection are important.
Key Features
- Droplet partitioning for PCR reactions into thousands of nanoliter droplets
- Endpoint fluorescence-based quantification for droplet digital PCR
- Designed for molecular biology and genomics ddPCR workflows
Specifications
- Voltage: 100-240 vac
- Frequency: 50/60 hz
- Current: 10a-4.6a
- Phase: single-phase
- Serial Number: 766BR2223
- Manufacture Date: 2023-08
- Country of Origin: United States
Weight
Imperial: 264.0 Pounds
Metric: 119.75 Kilograms
Shipping Dimensions
Imperial: 31.2 in x 57.6 in x 36.0 in
Metric: 79.25 cm x 146.3 cm x 91.44 cm
Product Enquiry
Have a question about this product? Send us your enquiry and our sales team will get back to you shortly.
Inform me when available
This item has sold. Leave your details and we will get in touch when a similar model becomes available.
Product Make Offer
Submit your best offer for this product. Our sales team will review your request and connect with you as soon as possible.
Comments 0
There are currently no public comments.